Puberty blocker use in New Zealand far higher than similar countries – study
New Zealand is prescribing up to seven times more puberty blockers to young transgender patients than other similar countries, new analysis shows.
New Zealand is prescribing up to seven times more puberty blockers to young transgender patients than other similar countries, new analysis shows.
Details of how and when Plunket nurses will step into providing childhood immunisations are still being finalised, say Plunket and Te Whatu Ora leaders.
Thousands of New Zealanders are failing to get proper screening for bowel cancer.
Pharmac is proposing to widen access to a medicine used in the treatment of chronic heart failure.
Hospital-based MRI and nuclear medicine technologists have stopped work for four days from 6am Friday morning.
The Government has just announced it’s ending what it calls a nearly 30-year ban on gene technology outside the lab. What does that mean? Science reporter Jamie Morton explains.
This year, according to data from the Institute of Environmental Science and Research, the Auckland metropolitan area has had the most hospitalisations from influenza-like illness since 2015.
The very idea of Pharmac presents a conundrum for the minister in charge, Act leader David Seymour.
New Zealand and the United States are the only high-income countries to allow unrestricted direct-to-consumer advertising of branded medicines, including the name of the drug and the condition for which it is prescribed.
Health New Zealand Te Whatu Ora has backed down on a plan to delay free access to a life-extending cancer drug after a backlash by patients and advocates.
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI